Heart failure with preserved ejection fraction: phantom or real independent syndrome with «own face»?
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4
Abstract
-
Authors and Affiliations
K. M. Amosova
Keywords
Related Articles
- EP ID EP451087
- DOI -
- Views 110
- Downloads 0
The protective effect of alpha-lipoic acid on cardiovascular diseases caused by oxidative stress
The article is devoted to the consideration of protective properties of alpha-lipoic acid using in cardiac patients, including those with concomitant type 2 diabetes mellitus, which constitute a group of high and very hi...
Prognostic significance of soluble ST2 as predictor of late left ventricular remodeling after ST-segment elevation myocardial infarction
The aim — to study the prognostic value of soluble ST2 regarding the development of pathological left ventricular remodeling (LVR) 6 months after acute ST‑ segment elevation myocardial infarction (STEMI) Materials and m...
Living activities limitation of population of Ukraine due to chronic venous diseases of lower limbs
The aim — to analyze the level and structure of primary (PD) and accumulated disability (AD) due to chronic venous diseases of the lower extremities (CVDLE) over the past five years in Ukraine. Materials and methods. T...
Phenotype-oriented approach to clinical evaluation of patients with chronic heart failure with preserved left ventricular ejection fraction
The aim — to establish the clinical significance of the phenotype‑based approach to assessing patients with verified heart failure (HF) with preserved left ventricular (LV) ejection (LV) fraction and its relationship wit...
Differences in the effects of various classes of antihypertensive drugs in combination therapy on indicators of arterial hemodynamics, vascular wall stiffness and structural-functional state of heart in patients with arterial hypertension of 1 — 2 degrees
The aim — to compare the effect of 6‑month treatment of patients with arterial hypertension (AH) of 1 — 2 degrees with angiotensin converting enzyme (ACE) or angiotensin II receptor blockers (ARB) in combination with a...